OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/13/2026
Back to search
Official data from USPTO
HYDIZYME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/13/2026
Trademark type
Word
Nice classes
5, 42
Filing date
01/08/2025
Registration date
02/03/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/03/2026
Last transaction
08/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
WILLIS, ALLYSON B
Law office
M40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
HuonsLab Co., Ltd.
Representatives
James R Menker Holley & Menker, PA
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; enzymes for veterinary purposes; ferments for pharmaceutical purposes; pharmaceutical agents for epidermis; cellular function activating agents for medical purposes; medicinal creams for skin care; enzymes for medical purposes; enzyme preparations for medical purposes; medicines for human purposesdrug delivery agents in liquid form for subcutaneous administration that facilitate the delivery of pharmaceutical preparations; enzyme preparations for medical purposes containing recombinant human hyaluronidase as an active ingredient; enzymes for medical purposes containing recombinant human hyaluronidase; medicated skin care preparations.
Class 42
Research and development of siRNA drugs; scientific research; research and development of vaccines and medicines; biomedical research services; drug discovery services; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical research services; research on the subject of pharmaceuticals; development of gene-based medicines; technical research in the field of pharmaceutical studies; testing of pharmaceuticals; consultancy in the field of testinginspectionresearch of medical products; medical research services.
Publications
History of USPTO decisions and trademark events.
24 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/07/2026
FIMP
FINAL DISPOSITION PROCESSED
08/07/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/27/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/26/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
02/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/16/2025
PUBO
PUBLISHED FOR OPPOSITION
12/16/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/17/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/14/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/14/2025
RFNT
REFUSAL PROCESSED BY IB
08/23/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/07/2025
RFRR
REFUSAL PROCESSED BY MPU
08/06/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/18/2025
CNRT
NON-FINAL ACTION WRITTEN
06/17/2025
DOCK
ASSIGNED TO EXAMINER
06/17/2025
MAFR
APPLICATION FILING RECEIPT MAILED
03/05/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/05/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/27/2025
Continuous trademark protection
Get notified about every new filing that threatens HYDIZYME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.